Nortis: Funding, Investors & Team (Oct 2026)
Nortis is a biotech company that has developed tissue-engineering techniques and organ-on-a-chip systems for the creation of a human micro-tissue environment within small, disposable, microfluidic chips. The company's technology enables living models of human organs that will drastically accelerate the discovery and introduction of new therapies and alleviate the use of lab animals. By growing tissue from human organ systems inside small microfluidic chips, researchers and assay developers can conduct in-vitro testing directly on functional human tissues. Nortis was founded in 2012 and is headquartered in Woodinville, Washington.
Nortis has raised $9.0M across 3 funding rounds on record, the most recent an undisclosed round of $6.0M announced in Aug 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nortis Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Nortis Funding Rounds
Nortis raised $1.5M in an undisclosed round announced in Jun 2021.
7 months later, a Debt Financing of $1.5M was announced in Jan 2022.
7 months later, an undisclosed round of $6.0M was announced in Aug 2022.
Nortis Founders and Leadership Team
Contact details for the Nortis team: 1 of 2 have an email address on file.
Start 14-day free trial →Nortis Funding Compared to Other Biotechnology Startups
Nortis' latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nortis in Biotechnology and Woodinville
Companies Similar to Nortis
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Nortis Funding FAQs
What does Nortis do?
Nortis is a biotech company that has developed tissue-engineering techniques and organ-on-a-chip systems for the creation of a human micro-tissue environment within small, disposable, microfluidic chips. The company's technology enables living models of human organs that will drastically accelerate the discovery and introduction of new therapies and alleviate the use of lab animals. By growing tissue from human organ systems inside small microfluidic chips, researchers and assay developers can conduct in-vitro testing directly on functional human tissues. Nortis was founded in 2012 and is headquartered in Woodinville, Washington.
How much funding has Nortis raised?
Nortis has raised $9.0M across 3 rounds on record. The most recent is an undisclosed round of $6.0M announced in Aug 2022.
When did Nortis last raise funding?
Nortis' most recent funding round on record is an undisclosed round of $6.0M, announced in Aug 2022.
Who founded Nortis?
FundedIQ lists Alan Nelson (Founder) at Nortis.
Who is the CEO of Nortis?
Thomas Neumann is listed as CEO at Nortis.
Where is Nortis headquartered?
Nortis is based in Woodinville, Washington, United States.
How many employees does Nortis have?
Nortis is in the 11-50 employee band.
How does Nortis' funding compare to other Biotechnology startups?
Nortis' latest round of $6.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nortis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nortis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.